Agilon Health Inc. (NYSE: AGL) reported Q4 EPS of ($0.46), $0.19 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $1.57 billion versus the consensus estimate of $1.46 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.